Nephros (NEPH) Cash from Investing Activities (2010 - 2022)
Nephros (NEPH) posted quarterly Cash from Investing Activities of -$103000.0 for Q2 2022, down 202.94% quarter-over-quarter from -$34000.0 in Q1 2022.
Nephros (NEPH) Cash from Investing Activities (2010 - 2022) Analysis & Trends
Nephros' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$103000.0 for Q2 2022.
- In Q2 2022, Cash from Investing Activities changed N/A year-over-year to -$103000.0; the TTM figure through Sep 2024 stood at -$103000.0 (changed N/A YoY), while the FY2024 annual figure was -$50000.0, up 33.33% from the prior year.
- Cash from Investing Activities for Q2 2022 stood at -$103000.0, down from -$34000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$13000.0 in Q3 2020, with the low at -$137000.0 in Q1 2019.
- The 4-year median for Cash from Investing Activities is -$34000.0 (2022), against an average of -$55142.9.
- The sharpest annual moves came in 2020 and 2021: Cash from Investing Activities grew 7.14% in 2020, then slumped 376.92% in 2021.
- Nephros' Cash from Investing Activities stood at -$14000.0 in 2019, then increased by 7.14% to -$13000.0 in 2020, then plunged by 376.92% to -$62000.0 in 2021, then sank by 66.13% to -$103000.0 in 2022.
- Business Quant data shows NEPH's Cash from Investing Activities at -$103000.0 in Q2 2022, -$34000.0 in Q1 2022, and -$62000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -103,000.00 |
| Jun 30, 2022 | -103,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -26,000.00 |
| Mar 31, 2016 | -26,000.00 |